Elisabet E Manasanch

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

American journal of hematology

Blood cancer journal

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Nianyi Li, Pei Lin, Zhuang Zuo, Mingjian James You, Wen Shuai, Robert Orlowski, Elisabet E Manasanch, Shaoying Li, Jie Xu, Sofia Garces, Fatima Zahra Jelloul, Zhenya Tang, Wei Wang, L Jeffrey Medeiros, Cheng Cameron Yin
Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis. Cancer medicine (2023)
Libere J Ndacayisaba, Kate E Rappard, Stephanie N Shishido, Sonia Maryam Setayesh, Guilin Tang, Pei Lin, Nicholas Matsumoto, Ching-Ju Hsu, Rafael Nevarez, Carmen Ruiz Velasco, Amin Naghdloo, Eric Yang, Kevin Kelly, James B Hicks, Jeremy Mason, Robert Z Orlowski, Elisabet E Manasanch, Peter Kuhn
Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms. International journal of molecular sciences 23 (21) (2022)
Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal, Sharmilan Thanendrarajan, Sabarinath Venniyil Radhakrishnan, Samer Al Hadidi, Carlyn Rose Tan, Sham Mailankody, Malin Hultcrantz, Neha Korde, Hani Hassoun, Alexander M Lesokhin, Sheeba K Thomas, Krina K Patel, Elisabet E Manasanch, Donna M Weber, Aniko Szabo, Gregory P Kaufman, Hans C Lee, Maurizio Zangari, Frits Van Rhee, Saad Z Usmani, Anita D Souza, Robert Z Orlowski, Carolina D Schinke
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience. American journal of hematology 97 (7) (2022)
Mohammed Alomari, Chutima Kunacheewa, Elisabet E Manasanch
The role of soluble B cell maturation antigen as a biomarker in multiple myeloma. Leukemia & lymphoma (2022)
Alyssa Clay-Gilmour, Subhayan Chattopadhyay, Michelle A T Hildebrandt, Hauke Thomsen, Niels Weinhold, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Christian Langer, Roman Hájek, Göran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Florentin Späth, Richard S Houlston, Hartmut Goldschmidt, Elisabet E Manasanch, Aaron Norman, Shaji K Kumar, Sundararajan Vincent Rajkumar, Susan L Slager, Asta Försti, Celine M Vachon, Kari Hemminki
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6. Blood cancer journal 12 (4) (2022)
Mahmoud R Gaballa, Junsheng Ma, Mikael Rauf, Roland L Bassett, Oren Pasvolsky, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, Regan Murphy, Katayoun Rezvani, Guillin Tang, Pei Lin, Hans C Lee, Krina K Patel, Muhammad R Ullah, Gregory P Kaufman, Elisabet E Manasanch, Partow Kebriaei, Sheeba K Thomas, Donna M Weber, Elizabeth J Shpall, Richard E Champlin, Robert Z Orlowski, Muzaffar H Qazilbash
KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma. Bone marrow transplantation 57 (7) (2022)
Elisabet E Manasanch, David Berrios, Eric Fountain, Catherine M Claussen, Tammy Chuang, Gregory Kaufman, Behrang Amini, Qaiser Bashir, Yago L Nieto, Muzaffar Qazilbash, Krina Patel, Sheeba K Thomas, Donna M Weber, Zuzana Berkova, Gokce Toruner, Pei Lin, Lei Feng, Hans C Lee, Robert Z Orlowski, Chutima Kunacheewa
Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies. British journal of haematology 192 (4) (2021)
Elisabet E Manasanch, Chutima Kunacheewa, Catherine M Claussen, Hans C Lee, Sheeba K Thomas, Jill Gunther, Chelsea C Pinnix, Bouthaina S Dabaja, Behrang Amini, Raymond Alexanian, Robert Z Orlowski, Wenli Dong, Lei Feng, Donna M Weber
Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up. Blood cancer journal 11 (2) (2021)
Elisabet E Manasanch, Preetesh Jain, Wendy Chen, Onyeka Oriabure, Maria Badillo, Lei Feng, Zuzana Berkova, Robert Z Orlowski, Michael L Wang
Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma. American journal of hematology 95 (9) (2020)
Elisabet E Manasanch, Guangchun Han, Rohit Mathur, Yun Qing, Zheng Zhang, Hans C Lee, Donna M Weber, Behrang Amini, Zuzana Berkova, Karina Eterovic, Shaojun Zhang, Jianhua Zhang, Xingzhi Song, Xizeng Mao, Margaret Morgan, Lei Feng, Veera Baladandayuthapani, Andrew Futreal, Linghua Wang, Sattva S Neelapu, Robert Z Orlowski
A pilot study of pembrolizumab in smoldering myeloma: report of the clinical, immune, and genomic analysis. Blood advances 3 (15) (2020)